Copenhagen, Jan 3 “2022 (Reuters) –
Kala duwanaanshaha coronavirus-ka Omicron ayaa ka fiican in la hareer maro difaaca dadka la tallaalay marka loo eego kala duwanaanshaha Delta, sida laga soo xigtay daraasad Danish ah oo la daabacay usbuucii hore, taasoo gacan ka geysaneysa sharraxaadda sababta Omicron uu si degdeg ah ugu faafo.
Tan iyo markii la helay kala duwanaanshaha Omicron ee aadka isu beddelay bishii Nofembar, saynisyahannadu waxay ku tartamayeen inay ogaadaan inay sababto cudur aan halis ahayn iyo sababta ay ugu muuqato inay ka faafi badan tahay noocii hore ee Delta.
Fayrasku waxa uu noqon karaa mid la kala qaado sababo badan awgood, sida wakhtiga uu hawada ku jiro, awoodda uu u leeyahay in uu unugyada ku dhego, ama uu ka baxsado habka difaaca jidhka.
Baadhitaanka ku dhawaad 12.000 oo qoys oo deenish ah bartamihii bishii Disembar, saynisyahannadu waxay ogaadeen, in Omicron uu 2.7 ilaa 3,7 jeer ka cudurka ka badan yahay noocyada Delta ee deenishka la tallaalay.
Daraasadda oo ay sameeyeen cilmi-baarayaal ka kala socda Jaamacadda Copenhagen, Statistics Danmark iyo Statens Serum Institut (SSI), ayaa soo jeedinaysa in fayrasku si degdeg ah u faafo, sababtoo ah way ka fiican tahay in laga fogaado difaaca laga helo tallaalka.
“Natiijooyinkayagu waxay xaqiijinayaan in fidinta degdega ah ee Omicron (kal壯陽藥 a duwanaanshaha) ugu horreyntii lagu tilmaami karo ka-baxsanaanta difaaca halkii ay ka ahaan lahayd kororka asalka ah ee gudbinta aasaasiga ah,” cilmi-baarayaashu waxay yiraahdeen. Daraasadda weli dib looma eegin.
Boqolkiiba 78 ee deenishka ayaa si buuxda loo tallaalay, halka ku dhawaad 48% dadkaasi ay heleen tallaalka saddexaad ee “la xoojiyay”. In ka badan siddeed ka mid ah tobankii qof ee deenish ah ayaa qaatay tallaalka Pfizer-BioNTech.
Daraasadu waxa kale oo ay ogaatay in dadka xoojiya tallaalka ay aad ugu yar yihiin gudbinta fayraska, iyada oo aan loo eegin kala duwanaanshaha, marka loo eego kuwa aan la tallaalin.
Iyadoo la kala qaadi karo, kala duwanaanshaha Omicron wuxuu u muuqdaa inuu keeno cudur aan halis ahayn, maamulaha farsamada SSI, Tyra Grove Krause, ayaa u sheegay warbaahinta maxaliga ah Isniintii.
“In kasta oo Omicron uu wali awoodi doono inuu cadaadis saaro nidaamkayaga daryeelka caafimaadka, wax walbana waxay muujinayaan inay ka khafiifsan tahay kala duwanaanshaha Delta,” ayay tidhi, iyada oo ku dartay khatarta ah in isbitaal lagu dhigo Omicron ay kala badh ka tahay tan Delta.
Taasi waxay ku nuuxnuuxsanaysaa natiijooyinka daraasadaha kale ee Omicron
